Results 11 to 20 of about 3,067,002 (353)

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

The Journal of Heart and Lung Transplantation, 2021
Tens of thousands of patients with advanced lung diseases may be eligible to be considered as potential candidates for lung transplant around the world each year.
L. Leard, A. Holm, Maryam Valapour, A. Glanville, S. Attawar, M. Aversa, S. V. Campos, Lillian Christon, M. Cypel, G. Dellgren, M. Hartwig, S. Kapnadak, N. Kolaitis, R. Kotloff, C. Patterson, O. Shlobin, Patrick J. Smith, A. Solé, M. Solomon, D. Weill, M. Wijsenbeek, B. Willemse, S. Arcasoy, K. Ramos   +23 more
semanticscholar   +1 more source

Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries

The Lancet Respiratory Medicine, 2021
Background Lung transplantation is a life-saving treatment for patients with end-stage lung disease; however, it is infrequently considered for patients with acute respiratory distress syndrome (ARDS) attributable to infectious causes.
A. Bharat, T. Machuca, Melissa Querrey, C. Kurihara, R. Garza-Castillon, Samuel Kim, Adwaiy Manerikar, A. Peláez, M. Pipkin, A. Shahmohammadi, M. Rackauskas, Suresh Kg, K. Balakrishnan, A. Jindal, L. Schaheen, S. Hashimi, Bhuvin Buddhdev, A. Arjuna, L. Rosso, A. Palleschi, Christian Lang, P. Jaksch, G. Budinger, M. Nosotti, K. Hoetzenecker   +24 more
semanticscholar   +1 more source

Azole-Induced Myositis after Combined Lung-Liver Transplantation

Case Reports in Transplantation, 2022
Lung transplant recipients experience a high rate of invasive pulmonary aspergillosis infections, for which voriconazole is the treatment of choice.
Sofie Happaerts, Michiel Wieërs, Ward Vander Mijnsbrugge, Laurent Godinas, Dirk Van Raemdonck, Laurens J. Ceulemans, Robin Vos, Geert M. Verleden   +7 more
doaj   +1 more source

Ischemia–Reperfusion Injury in Lung Transplantation

Cells, 2021
Lung transplantation has been established worldwide as the last treatment for end-stage respiratory failure. However, ischemia–reperfusion injury (IRI) inevitably occurs after lung transplantation.
T. Chen-Yoshikawa
semanticscholar   +1 more source

Evolution of the Surgical Management of Lung Cancer Invading the Spine: A Single Center Experience

Current Oncology, 2022
For patients with locally advanced non-small cell lung cancer invading the spine, induction chemoradiotherapy combined with radical en bloc resection is the key to obtaining long-term survival.
Gabrielle Drevet, Théo Broussolle, Yanis Belaroussi, Lucie Duponchelle, Jean Michel Maury, Renaud Grima, Gualter Vaz, Clément Silvestre, François Tronc   +8 more
doaj   +1 more source

Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing

American Journal of Transplantation, 2021
We describe a case of proven transmission of SARS‐CoV‐2 from lung donor to recipient. The donor had no clinical history or findings suggestive of infection with SARS‐CoV‐2 and tested negative by reverse transcriptase polymerase chain reaction (RT‐PCR) on
Daniel R. Kaul, A. Valesano, J. Petrie, R. Sagana, D. Lyu, Jules Lin, Emily Stoneman, L. M. Smith, Paul R Lephart, A. Lauring   +9 more
semanticscholar   +1 more source

Lung transplantation for interstitial lung disease

European Respiratory Review, 2021
Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis
S. Kapnadak, G. Raghu
semanticscholar   +1 more source

Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease.

The Journal of Heart and Lung Transplantation, 2021
BACKGROUND Idiopathic pulmonary fibrosis (IPF) is the most common indication for lung transplantation in North America and variants in telomere-maintenance genes are the most common identifiable cause of IPF.
J. Alder, R. Sutton, C. Iasella, M. Nouraie, R. Koshy, S. Hannan, E. Chan, Xiaoping Chen, Yingze Zhang, Mark Brown, I. Popescu, M. Veatch, M. Saul, A. Berndt, B. Methé, A. Morris, J. Pilewski, P. Sanchez, M. Morrell, S. Shapiro, K. Lindell, K. Gibson, D. Kass, J. McDyer   +23 more
semanticscholar   +1 more source

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

Respiratory Research, 2020
Background Serum chitotriosidase is a promising biomarker that has shown high specificity and sensitivity in patients with sarcoidosis. The aim of this study was to investigate correlations between serum chitotriosidase, clinical phenotypes, disease ...
David Bennett, Paolo Cameli, Nicola Lanzarone, Loredana Carobene, Nicola Bianchi, Annalisa Fui, Luigi Rizzi, Laura Bergantini, Giuseppe Cillis, Miriana d’Alessandro, Maria Antonietta Mazzei, Rosa Metella Refini, Piersante Sestini, Elena Bargagli, Paola Rottoli   +14 more
doaj   +1 more source

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report

BMC Pulmonary Medicine, 2022
Background Variability in triazole plasma concentrations by drug interactions is well known. An interaction between voriconazole and flucloxacillin has already been described.
Saartje Verfaillie, Laurent Godinas, Isabel Spriet, Robin Vos, Geert M. Verleden   +4 more
doaj   +1 more source